Alloy vs Factor Health MD
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Factor Health MD
Best for Cost-sensitive buyers seeking the broadest compounded GLP-1 selection (sema + tirz + liraglutide) at aggressive $99-$150/mo pricing with HSA/FSA payment acceptance and multi-product wellness platform consolidation. Particularly fit for patients seeking liraglutide specifically — rare in the DTC compounded market.Starting at $99/mo
Side-by-Side Comparison
| Feature | Alloy | Factor Health MD |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.4/10 |
| Starting Price | ✓$80/mo | $99/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.2 ★ /5 |
| Features | 8 features | ✓13 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Factor Health MD
Pros
- ✓**3-GLP-1 lineup including liraglutide** — rare in the DTC market. Most platforms offer only semaglutide + tirzepatide. Liraglutide is older but still FDA-approved (as Saxenda for weight loss) and may suit patients sensitive to newer molecules or seeking shorter half-life.
- ✓Aggressive $99/mo starting tier with 'all doses included' framing — competitive entry pricing
- ✓Multi-product platform (GLP-1 + longevity + vitamin injectables + men's health + bundles)
- ✓HSA/FSA accepted (uncommon in DTC compounded GLP-1 market)
- ✓St Petersburg FL location anchor + phone (305-930-8817) for accountability
- ✓LegitScript verification badge displayed
- ✓Free medical consultations framing
- ✓'We don't increase the price per dose' = no per-tier price escalation as patients titrate up
Cons
- ✗Specific 503A/503B pharmacy partner NOT named
- ✗LegitScript ID NUMBER not visible in text (only badge displayed)
- ✗Full states-served list NOT disclosed publicly
- ✗Named medical director NOT disclosed
- ✗Verbatim FDA compounded-medication disclaimer text NOT prominently displayed
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed (footer copyright shows '2025' year)
- ✗Governing law / arbitration venue NOT disclosed
- ✗Compounded liraglutide has weaker evidence base for weight loss vs sema/tirz (older molecule, lower-magnitude TBWL in trials)
- ✗Tirzepatide pricing tier ($149/mo) less explicit than the $99 starting price advertised most prominently
Our Verdict
Alloy edges out Factor Health MD with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. Factor Health MD remains a solid alternative, especially if you're looking for Cost-sensitive buyers seeking the broadest compounded GLP-1 selection (sema + tirz + liraglutide) at aggressive $99-$150/mo pricing with HSA/FSA payment acceptance and multi-product wellness platform consolidation. Particularly fit for patients seeking liraglutide specifically — rare in the DTC compounded market..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.